Обзор новых клинических рекомендаций по диагностике и лечению фибрилляции предсердий (2016 г.) Европейского кардиологического общества в сотрудничестве с Европейской ассоциацией кардиоторакальных хирургов

фибрилляция предсердий, диагностика, лечение, новые клинические рекомендации, atrial fibrillation, diagnosis, treatment, novel clinical recommendation

1. Camm A.J., Kirchhof P., Lip G. Y. H. et al. Guidelines for the management of atrial fibrillation. The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology. Eur Heart J 2010;31:2369-2429.

2. Connolly S.J., Eikelboom J., Joyner C. et al., for the AVERROES Steering Committee and Investigators. Apixaban in Patients with Atrial Fibrillation. N Engl J Med 2011;364:806-817.

3. Patel M. R., Mahaffey K. W., Garg J. et al. and the ROCKET AF Steering Committee, for the ROCKET AF Investigators. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation. N Engl J Med 2011; 365:883-891.

4. Granger C. B., Alexander J. H., McMurray J. J. V. et al. for the ARISTOTLE Committees and Investigators. Apixaban versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med 2011;365:981-992.

5. Camm A.J., Lip G. Y. H., De Caterina R. et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Eur Heart J 2012;33:2719-2747.

6. Kirchhof P., Benussi S., Kotecha D. et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016;37 (38):2893-2962.

7. Lowres N., Neubeck L., Redfern J., Freedman S. B. Screening to identify unknown atrial fibrillation. A systematic review. Thromb Haemost 2013;110:213-222.

8. Jabaudon D., Sztajzel J., Sievert K. et al. Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke 2004;35 (7):1647-1651.

9. Chao T. F., Suenari K., Chang S. L. et al. Atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation associated with diabetes mellitus or impaired fasting glucose. Am J Cardiol 2010;106:1615-1620.

10. Albertsen I. E., Rasmussen L. H., Lane D. A. et al. The impact of smoking on thromboembolism and mortality in patients with incident atrial fibrillation: insights from the Danish Diet, Cancer, and Health study. Chest 2014;145:559-566.

11. Overvad T. F., Rasmussen L. H., Skjoth F. et al. Alcohol intake and prognosis of atrial fibrillation. Heart 2013;99:1093-1099.

12. Regitz-Zagrosek V., Blomstrom Lundqvist C., Borghi C. et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J 2011;32:3147-3197.

13. Jacobs L. G., Billett H. H., Freeman K. et al. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study. Am J Geriatr Pharmacother 2009;7:159-166.

14. Roffi M., Patrono C., Collet J. P. et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2015. doi /10.1093 /eurheartj /ehv320.

15. Lip G. Y., Windecker S., Huber K. et al. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association, European Association of Percutaneous Cardiovascular Interventions and European Association of Acute Cardiac Care endorsed by the Heart Rhythm Society and Asia-Pacific Heart Rhythm Society. Eur Heart J 2014;35:3155-3179.